Citrate Salt of 1 - (pyrrolidin-1-yl dioxa 14,30 - ethoxy) - - - - - 5,7,26 triaza tetraciclo (19.3.1.1 (2.6). Heptacosa (8.12) - 1 - (25), 2 (26), 3,5,8,10,12 (27), 16,21,23 - decaeno

摘要

Also to pharmaceutical compositions that contain Salt and Methods of use of the Citrate Salt of citrate in the treatment of certain medical conditions, such as proliferative disorders. Claim 1: a Citrate Salt characterized by 11 - (pyrrolidin-1-yl dioxa 14,30 - ethoxy) - - - - - 5,7,26 triaza tetraciclo [19.3.1.1 (2.6).1 (8.12)] heptacosa (25 - 1), 2 (26), 3,5,8,10,12 (27), 16,21,23 - decaeno formula (1)